Biotrial, one of the leaders in early clinical development, by variablepitch349



Biotrial, one of the leaders in early clinical development, expands its market reach and will be showcasing at two major Pharmaceutical and Biotech Industry events in March 2009.
Rennes, France — March 10th, 2009 Biotrial, who has developed an extensive experience with Biotech companies, will be participating in the BIO-Europe Spring 2009 conference. This event, the springtime counterpart of BIO-Europe (, brings together leading international pharmaceutical and biotech companies from March 16–18, 2009 in Milan, Italy, at the Milano Convention Center (MIC). As a leading Contract Research Organization, Biotrial offers biotech companies a global solution tailored to their product development, encompassing early non clinical phase (including toxicology studies), Phase I, Phase II and on. People attending this event are able to set direct meetings with the Biotrial team through the partneringONE system ( which allows attendees to have direct access to the Biotrial team agenda and make appointments. Didier Chassard, MD, Associate Medical and Scientific Director at Biotrial will present. Later in the month another Biotrial team will be exhibiting the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) ( in Washington DC, March 1821, 2009. Since 1989, Biotrial offers a wide range of services in the clinical development arena from Phase I, proof of concept, QT studies to central ECG laboratory, biostatistics, report writing, and so forth. “Alain Patat, Biotrial VP of Medical and Scientific Affairs, and I are excited to attend this event again this year,” said Jean-Marc Gandon, Biotrial CEO. “It is an essential conference for people involved with pharmacology worldwide. For us it is a great opportunity to listen to talks given by key professionals and specialists, to visit with our clients in an informal setting, and to explore possible collaborations with other sponsors.” Biotrial will be exhibiting at ASCPT’s Booth #100.

To top